These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 8966866)

  • 21. Intraocular pressure reduction with topically administered pilocarpine, timolol and betaxolol in normal tension glaucoma.
    Nyman K
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):686-90. PubMed ID: 8109215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Xalathane: comparative assessment of efficacy and safety in hypotensive therapy of glaucoma].
    Erichev VP; Iakubova LV
    Vestn Oftalmol; 1998; 114(4):20-1. PubMed ID: 9771081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study.
    Kumar H; Sudan R; Sethi HS; Sony P
    Indian J Ophthalmol; 2002 Mar; 50(1):21-3. PubMed ID: 12090082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of timolol-dorzolamide and timolol-pilocarpine combinations on ocular blood flow in patients with glaucoma.
    Uva MG; Longo A; Reibaldi M; Reibaldi A
    Am J Ophthalmol; 2006 Jun; 141(6):1158-60. PubMed ID: 16765700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The long-term hypotensive effect of timolol maleate compared with the effect of pilocarpine in simple and capsular glaucoma.
    Airaksinen PJ
    Acta Ophthalmol (Copenh); 1979 Jun; 57(3):425-34. PubMed ID: 38623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The separate and combined use of timoptic depot].
    Egorov EA; Stavitskaia TV; Voĭtova SP
    Vestn Oftalmol; 1999; 115(3):28-30. PubMed ID: 10432851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timolol versus pilocarpine separately or combined with acetazolamide-effects on intraocular pressure.
    Calissendorff B; Marén N; Wettrell K; Ostberg A
    Acta Ophthalmol (Copenh); 1980 Aug; 58(4):624-31. PubMed ID: 7010886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I; Clineschmidt C; Polis A; Taylor J; Shedden A; Laibovitz R
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers.
    Schmetterer L; Strenn K; Findl O; Breiteneder H; Graselli U; Agneter E; Eichler HG; Wolzt M
    Clin Pharmacol Ther; 1997 May; 61(5):583-95. PubMed ID: 9164420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of acute closed-angle glaucoma with miotics and timolol.
    Airaksinen PJ; Saari KM; Tiainen TJ; Jaanio EA
    Br J Ophthalmol; 1979 Dec; 63(12):822-5. PubMed ID: 526463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-Blockers and the eye: an overview.
    Katz IM
    Ann Ophthalmol; 1978 Jul; 10(7):847-50. PubMed ID: 28061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.
    Shafaa MW; Sabra NM; Fouad RA
    Biopharm Drug Dispos; 2011 Dec; 32(9):507-17. PubMed ID: 22028305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.
    Magacho L; Reis R; Shetty RK; Santos LC; Avila MP
    Ophthalmology; 2006 Mar; 113(3):442-5. PubMed ID: 16458964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
    Shin DH; McCracken MS; Bendel RE; Pearlman R; Juzych MS; Hughes BA; Schulz LL; Kim C; Baek NH
    Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.